{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "25517390", "DateCompleted": {"Year": "2015", "Month": "09", "Day": "23"}, "DateRevised": {"Year": "2019", "Month": "12", "Day": "10"}, "Article": {"Language": ["eng", "por"], "ArticleDate": [{"Year": "2014", "Month": "12", "Day": "16"}], "ELocationID": ["10.5935/abc.20140192", "S0066-782X2014005040192"], "Journal": {"ISSN": "1678-4170", "JournalIssue": {"Volume": "104", "Issue": "3", "PubDate": {"Year": "2015", "Month": "Mar"}}, "Title": "Arquivos brasileiros de cardiologia", "ISOAbbreviation": "Arq Bras Cardiol"}, "ArticleTitle": "Role of microRNAs 221/222 on statin induced nitric oxide release in human endothelial cells.", "Pagination": {"StartPage": "195", "EndPage": "201", "MedlinePgn": "195-201"}, "Abstract": {"AbstractText": ["Nitric oxide (NO) has been largely associated with cardiovascular protection through improvement of endothelial function. Recently, new evidence about modulation of NO release by microRNAs (miRs) has been reported, which could be involved with statin-dependent pleiotropic effects, including anti-inflammatory properties related to vascular endothelium function.", "To evaluate the effects of cholesterol-lowering drugs including the inhibitors of cholesterol synthesis, atorvastatin and simvastatin, and the inhibitor of cholesterol absorption ezetimibe on NO release, NOS3 mRNA expression and miRs potentially involved in NO bioavailability.", "Human umbilical vein endothelial cells (HUVEC) were exposed to atorvastatin, simvastatin or ezetimibe (0 to 5.0 \u03bcM). Cells were submitted to total RNA extraction and relative quantification of NOS3 mRNA and miRs -221, -222 and -1303 by qPCR. NO release was measured in supernatants by ozone-chemiluminescence.", "Both statins increased NO levels and NOS3 mRNA expression but no influence was observed for ezetimibe treatment. Atorvastatin, simvastatin and ezetimibe down-regulated the expression of miR-221, whereas miR-222 was reduced only after the atorvastatin treatment. The magnitude of the reduction of miR-221 and miR-222 after treatment with statins correlated with the increment in NOS3 mRNA levels. No influence was observed on the miR-1303 expression after treatments.", "NO release in endothelial cells is increased by statins but not by the inhibitor of cholesterol absorption, ezetimibe. Our results provide new evidence about the participation of regulatory miRs 221/222 on NO release induction mediated by statins. Although ezetimibe did not modulate NO levels, the down-regulation of miR-221 could involve potential effects on endothelial function."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departamento de An\u00e1lises Cl\u00ednicas e Toxicol\u00f3gicas, Faculdade de Ci\u00eancias Farmac\u00eauticas, Universidade de S\u00e3o Paulo, SP, Brasil."}], "LastName": "Cerda", "ForeName": "Alvaro", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departamento de An\u00e1lises Cl\u00ednicas e Toxicol\u00f3gicas, Faculdade de Ci\u00eancias Farmac\u00eauticas, Universidade de S\u00e3o Paulo, SP, Brasil."}], "LastName": "Fajardo", "ForeName": "Cristina Moreno", "Initials": "CM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departamento de An\u00e1lises Cl\u00ednicas e Toxicol\u00f3gicas, Faculdade de Ci\u00eancias Farmac\u00eauticas, Universidade de S\u00e3o Paulo, SP, Brasil."}], "LastName": "Basso", "ForeName": "Rodrigo Gouveia", "Initials": "RG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departamento de An\u00e1lises Cl\u00ednicas e Toxicol\u00f3gicas, Faculdade de Ci\u00eancias Farmac\u00eauticas, Universidade de S\u00e3o Paulo, SP, Brasil."}], "LastName": "Hirata", "ForeName": "Mario Hiroyuki", "Initials": "MH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departamento de An\u00e1lises Cl\u00ednicas e Toxicol\u00f3gicas, Faculdade de Ci\u00eancias Farmac\u00eauticas, Universidade de S\u00e3o Paulo, SP, Brasil."}], "LastName": "Hirata", "ForeName": "Rosario Dominguez Crespo", "Initials": "RD"}], "PublicationTypeList": ["Evaluation Study", "Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Brazil", "MedlineTA": "Arq Bras Cardiol", "NlmUniqueID": "0421031", "ISSNLinking": "0066-782X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anticholesteremic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Azetidines"}, {"RegistryNumber": "0", "NameOfSubstance": "Heptanoic Acids"}, {"RegistryNumber": "0", "NameOfSubstance": "MIRN221 microRNA, human"}, {"RegistryNumber": "0", "NameOfSubstance": "MIRN222 microRNA, human"}, {"RegistryNumber": "0", "NameOfSubstance": "MicroRNAs"}, {"RegistryNumber": "0", "NameOfSubstance": "Pyrroles"}, {"RegistryNumber": "31C4KY9ESH", "NameOfSubstance": "Nitric Oxide"}, {"RegistryNumber": "A0JWA85V8F", "NameOfSubstance": "Atorvastatin"}, {"RegistryNumber": "AGG2FN16EV", "NameOfSubstance": "Simvastatin"}, {"RegistryNumber": "EC 1.14.13.39", "NameOfSubstance": "NOS3 protein, human"}, {"RegistryNumber": "EC 1.14.13.39", "NameOfSubstance": "Nitric Oxide Synthase Type III"}, {"RegistryNumber": "EOR26LQQ24", "NameOfSubstance": "Ezetimibe"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Analysis of Variance"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Anticholesteremic Agents"}, {"QualifierName": [], "DescriptorName": "Atorvastatin"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Azetidines"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": [], "DescriptorName": "Cells, Cultured"}, {"QualifierName": [], "DescriptorName": "Down-Regulation"}, {"QualifierName": ["drug effects"], "DescriptorName": "Endothelium, Vascular"}, {"QualifierName": [], "DescriptorName": "Ezetimibe"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Heptanoic Acids"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Human Umbilical Vein Endothelial Cells"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Luminescence"}, {"QualifierName": ["metabolism"], "DescriptorName": "MicroRNAs"}, {"QualifierName": ["metabolism"], "DescriptorName": "Nitric Oxide"}, {"QualifierName": ["metabolism"], "DescriptorName": "Nitric Oxide Synthase Type III"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Pyrroles"}, {"QualifierName": [], "DescriptorName": "Real-Time Polymerase Chain Reaction"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Simvastatin"}], "CoiStatement": "<b>Potential Conflict of Interest</b>. No potential conflict of interest relevant to this article was reported."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105(9):1135\u20131143.", "ArticleIdList": ["11877368"]}, {"Citation": "F\u00f6rstermann U, M\u00fcnze T. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation. 2006;113(13):1708\u20131714.", "ArticleIdList": ["16585403"]}, {"Citation": "Lei J, Vodovotz Y, Tzeng E, Billiar TR. Nitric oxide, a protective molecule in the cardiovascular system. Nitric Oxide. 2013;35:135\u2013185.", "ArticleIdList": ["24095696"]}, {"Citation": "Searles CD. Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression. Am J Physiol Cell Physiol. 2006;291(5):C803\u2013C816.", "ArticleIdList": ["16738003"]}, {"Citation": "Qian J, Fulton D. Post-translational regulation of endothelial nitric oxide synthase in vascular endothelium. Front Physiol. 2013;4:347\u2013347.", "ArticleIdList": ["PMC3861784", "24379783"]}, {"Citation": "Su\u00e1rez Y, Fern\u00e1ndez-Hernando C, Pober JS, Sessa WC. Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells. Circ Res. 2007;100(8):1164\u20131173.", "ArticleIdList": ["17379831"]}, {"Citation": "Mangravite LM, Thorn CF, Krauss RM. Clinical implications of pharmacogenomics of statin treatment. Pharmacogenomics J. 2006;6(6):360\u2013374.", "ArticleIdList": ["16550210"]}, {"Citation": "Bays HE, Neff D, Tomassini JE, Tershakovec AM. Ezetimibe: cholesterol lowering and beyond. Expert Rev Cardiovasc Ther. 2008;6(4):447\u2013470.", "ArticleIdList": ["18402536"]}, {"Citation": "Mihos CG, Salas MJ, Santana O. The pleiotropic effects of the hydroxymethyl- glutaryl-CoA reductase inhibitors in cardiovascular disease: a comprehensive review. Cardiol Rev. 2010;18(6):298\u2013304.", "ArticleIdList": ["20926939"]}, {"Citation": "Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3(7):", "ArticleIdList": ["PMC126239", "12184808"]}, {"Citation": "Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402\u2013408.", "ArticleIdList": ["11846609"]}, {"Citation": "Aoki C, Nakano A, Tanaka S, Yanagi K, Ohta S, Jojima T, et al. Fluvastatin upregulates endothelial nitric oxide synthase activity via enhancement of its phosphorylation and expression and via an increase in tetrahydrobiopterin in vascular endothelial cells. Int J Cardiol. 2012;156(1):55\u201361.", "ArticleIdList": ["21093076"]}, {"Citation": "Rossoni LV, Wareing M, Wenceslau CF, Al-Abri M, Cobb C, Austin C. Acute simvastatin increases endothelial nitric oxide synthase phosphorylation via AMP-activated protein kinase and reduces contractility of isolated rat mesenteric resistance arteries. Clin Sci (Lond) 2011;121(10):449\u2013458.", "ArticleIdList": ["PMC3174052", "21671887"]}, {"Citation": "Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh R, et al. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature. 1999;399(6736):597\u2013601. Erratum in: Nature 1999;400(6746):792.", "ArticleIdList": ["PMC3637917", "10376602"]}, {"Citation": "Ye Y, Martinez JD, Perez-Polo RJ, Lin Y, Uretsky BF, Birnbaum Y. The role of eNOS, iNOS, and NF-kappaB in upregulation and activation of cyclooxygenase-2 and infarct size reduction by atorvastatin. Am J Physiol Heart Circ Physiol. 2008;295(1):H343\u2013H351.", "ArticleIdList": ["18469150"]}, {"Citation": "Stalker TJ, Lefer AM, Scalia R. A new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: the role of mevalonic acid. Br J Pharmacol. 2001;133(3):406\u2013412.", "ArticleIdList": ["PMC1572789", "11375257"]}, {"Citation": "Ni R, Peleg T, Gross PL. Atorvastatin delays murine platelet activation in vivo even in the absence of endothelial NO synthase. Arterioscler Thromb Vasc Biol. 2012;32(11):2609\u20132615.", "ArticleIdList": ["22995523"]}, {"Citation": "Pan ZW, Lu YJ, Yang BF. MicroRNAs: a novel class of potential therapeutic targets for cardiovascular diseases. Acta Pharmacol Sin. 2010;31(1):1\u20139.", "ArticleIdList": ["PMC4002691", "19966833"]}, {"Citation": "Liu X, Cheng Y, Zhang S, LinY, Yang J, Zhang C. A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res. 2009;104(4):476\u2013487.", "ArticleIdList": ["PMC2728290", "19150885"]}, {"Citation": "Minami Y, Satoh M, Malsawa C, Takahashi Y, Tabuchi T, Itoh T, et al. Effect of atorvastatin on microRNA 221 / 222 expression in endothelial progenitor cells obtained from patients with coronary artery disease. Eur J Clin Invest. 2009;39(5):359\u2013367.", "ArticleIdList": ["19371267"]}, {"Citation": "Rippe C, Blimline M, Magerko KA, Lawson BR, LaRocca TJ, Donato AJ, et al. MicroRNA changes in human arterial endothelial cells with senescence: relation to apoptosis, eNOS and inflammation. Exp Gerontol. 2012;47(1):45\u201351.", "ArticleIdList": ["PMC3245334", "22037549"]}, {"Citation": "Mu\u00f1oz-Pacheco P, Ortega-Hern\u00e1ndez A, Miana M, Cachofeiro V, Fern\u00e1ndez-Cruz A, G\u00f3mez-Garre D. Ezetimibe inhibits PMAinduced monocyte/macrophage differentiation by altering microRNA expression: a novel anti-atherosclerotic mechanism. Pharmacol Res. 2012;66(6):536\u2013543.", "ArticleIdList": ["22989505"]}], "ReferenceList": []}], "History": [{"Year": "2014", "Month": "7", "Day": "9"}, {"Year": "2014", "Month": "9", "Day": "18"}, {"Year": "2014", "Month": "12", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2014", "Month": "12", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2015", "Month": "9", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2015", "Month": "3", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["25517390", "PMC4386847", "10.5935/abc.20140192", "S0066-782X2014005040192"]}}], "PubmedBookArticle": []}